纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
- 种属
- Cynomolgus
- 表达系统
- HEK293
蛋白结构
LILRB1 (41–474)
His加载中…
加载中…
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per ug by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
| 分子名 | 目录号 | 种属 | 表达宿主 | 产品描述 | 蛋白结构 |
|---|---|---|---|---|---|
| LILRB1 | LILRB1-CP004 | Cynomolgus | HEK293 | Cynomolgus LILRB1/CD85j/ILT2 Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | LILRB1 (41–474) His |
| HLA-E*01:03 | HLAE0103-HP004 | Human | HEK293 | Human Peptide Ready HLA-E*01:03&B2M Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| KRAS G12C | KRASG12C-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Tetramer Protein, Ultra Low Endotoxin 纯度 > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg | KRAS G12C (25–305) AviHis |
| FcRn | FCRN-AB001 | Human | HEK293 | Anti-FcRn Antibody (Rozanolixizumab Biosimilar) 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | FcRn |
| KRAS G12V | KRASG12V-HB004 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| AFP | AFP-HP005 | Human | HEK293 | Human HLA-A*02:01&B2M&AFP (PLFQVPEPV) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per ug by the LAL method. 100 μg | AFP (25–305) AviHis |
| LILRB1 | LILRB1-HP002 | Human | HEK293 | Human LILRB1/CD85j/ILT2 Protein 纯度 > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | LILRB1 (116–461) His |
| MAGE-A1 | MAGEA1-HP005 | Human | HEK293 | Chimeric HLA-A*02:01 (mα3) &mB2M&MAGE-A1 (KVLEYVIKV) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A1 (25–206) His |
| KRAS G12R | KRASG12R-HP002 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Tetramer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12R (25–305) AviHis |
| AFP | AFP-HP008 | Human | HEK293 | Human HLA-A*02:03&B2M&AFP (FMNKFIYEI) Tetramer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | AFP (25–305) AviHis |
| KRAS G12D | KRASG12D-HP006 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| NY-ESO-1 | NYESO1-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein, Ultra Low Endotoxin 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
| TERT | TERT-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&TERT (ILAKFLHWL) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | TERT (25–305) AviHis |
| HLA-A*31:01 | HLAA3101-HP001 | Human | HEK293 | Human Peptide Ready HLA-A*31:01&B2M Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.1 EU per μg by the LAL method. 100 μg | HLA-A*31:01 (25–305) AviHis |
| LMP2 | LMP2-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Tetramer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | LMP2 (25–305) AviHis |
| KRAS G12D | KRASG12D-HB001 | Human | HEK293 | Biotinylated Human KRAS G12D TCR&CD3 Complex Nanodisc 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D His |
| EGFR WT | EGFRWT-HB002 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&EGFR WT (KITDFGLAK) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | EGFR WT (25–305) AviHis |
| HLA-E*01:03 | HLAE0103-HB001 | Human | HEK293 | Biotinylated Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| HPV16 E7 | HPV16E7-HP001 | Human | HEK293 | Human HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E7 (25–305) AviHis |
| NY-ESO-1 | NYESO1-HB004 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
